The present experiments examine the effects of maturation on cyclic GMP (cGMP)-mediated vasodilation in 688 segments of common carotid (COM) and basilar (BAS) arteries taken from newborn (3-to 7-d-old) and nonpregnant adult sheep. The main finding is that maximum efficacy for relaxation decreased with maturation in both artery types for the nitric oxide releasing vasodilators S-nitroso-N-acetyl-penicillamine and nitroglycerin. These decreases could not be explained by changes in the -log ED,, concentrations for either vasodilator. Determination of the time course of cGMP responses to S-nitroso-Nacetyl-penicillamine or nitroglycerin at 10 FM revealed that the peak cGMP responses to these agents (range: 5.3 2 0.8 to 8.3 a 1.6 pmollmg of protein) also did not vary significantly with age. However, cGMP attained peak values more rapidly in adult (COM: 50 s; BAS 30 s) than in newborn (COM: 60-80 s: BAS, 4 M 0 s) segments and returned to baseline more slowly in newborn than in adult segments, suggesting that maturation accelerates cGMP turnover. Correspondingly, baseline levels of cGMP were In most arteries, vascular structure and function are immature at birth and change markedly during early postnatal life (1). In the cerebral circulation, this immaturity may be particularly important, because it may contribute to the high incidence of cerebrovascular complications observed in neonates (2, 3). Among the few studies that have directly examined maturational changes in cerebral arteries, however, most have found that vasoconstrictor reactivity is generally higher in immature than in mature cerebral arteries (1, 4-6). Thus, the high incidence of neonatal cerebrovascular complications seems not to be a consequence of a deficit in the ability of cerebral arteries to respond to vasoconstrictor stimuli. Alternatively, it remains possible that altered mechanisms of cerebral vasorelaxation may be involved. If Supported by PHs Grant HL11347 and Grant 92-293A from the American Heart Association.
The present experiments examine the effects of maturation on cyclic GMP (cGMP)-mediated vasodilation in 688 segments of common carotid (COM) and basilar (BAS) arteries taken from newborn (3-to 7-d-old) and nonpregnant adult sheep. The main finding is that maximum efficacy for relaxation decreased with maturation in both artery types for the nitric oxide releasing vasodilators S-nitroso-N-acetyl-penicillamine and nitroglycerin. These decreases could not be explained by changes in the -log ED,, concentrations for either vasodilator. Determination of the time course of cGMP responses to S-nitroso-Nacetyl-penicillamine or nitroglycerin at 10 FM revealed that the peak cGMP responses to these agents (range: 5.3 2 0.8 to 8.3 a 1.6 pmollmg of protein) also did not vary significantly with age. However, cGMP attained peak values more rapidly in adult (COM: 50 s; BAS 30 s) than in newborn (COM: 60-80 s: BAS, 4 M 0 s) segments and returned to baseline more slowly in newborn than in adult segments, suggesting that maturation accelerates cGMP turnover. Correspondingly, baseline levels of cGMP were In most arteries, vascular structure and function are immature at birth and change markedly during early postnatal life (1) . In the cerebral circulation, this immaturity may be particularly important, because it may contribute to the high incidence of cerebrovascular complications observed in neonates (2, 3) . Among the few studies that have directly examined maturational changes in cerebral arteries, however, most have found that vasoconstrictor reactivity is generally higher in immature than in mature cerebral arteries (1, (4) (5) (6) . Thus, the high incidence of neonatal cerebrovascular complications seems not to be a consequence of a deficit in the ability of cerebral arteries to respond to vasoconstrictor stimuli. Alternatively, it remains possible that altered mechanisms of cerebral vasorelaxation may be involved. If newborn arteries have a greater propensity to relax, they may be less capable of resisting the vascular injury and rupture often associated with insults, such as asphyxia and transient hypertension, that markedly elevate cerebral perfusion. Mechanisms of cerebral vasorelaxation, however, have thus far received relatively little direct experimental attention in neonates.
One of the most important pathways for vasorelaxation is that mediated by changes in vascular guanylate cyclase activity. Increases in cGMP synthesis mediate the vasodilatory responses to nitrovasodilators, atrial natriuretic peptide, and also nitric oxide released from either perivascular neurons or vascular endothelial cells (7) (8) (9) . Recent evidence further suggests that, in adults of some species, changes in cGMP may also be involved in cerebrovascular responses to hypercapnia (10) and possibly also hypoxia (11, 12) . Other studies suggest that the sensitivity of guanylate cyclase to nitric oxide may change during maturation, at least in the pulmonary circulation (13). Given the central importance of the guanyl-ate cyclase-cGMP pathway, its potential modulation by maturation, and the fact that it has been little studied in the cerebral circulation, the present studies address the hypothesis that maturation modulates the cGMP pathway for relaxation in cerebral arteries.
To explore this hypothesis, we have examined and compared cGMP-dependent, but endothelium-independent, relaxation in arteries isolated from newborn and adult sheep. Given previous suggestions of important intracranial-extracranial differences in patterns of relaxation in this model (14, 15), we studied both common carotid and basilar arteries. In light of suggestions that maturation may alter the capacity for biotransformation of NG (14), we examined two cGMP-dependent vasodilators: NG, which requires intracellular biotransformation for its action, and S-nitroso-N-acetyl-penicillamine, which does not. For both of these agents, we examined the effects of maturation on their dose-response relations and on the dynamic relations between relaxation and cGMP synthesis.
METHODS
All procedures and protocols used in the present studies were approved by the Animal Research Committee of Loma Linda University and followed all guidelines put forth in the NIH Guide for the Care and Use of Laboratory Animals.
We obtained basilar and common carotid arteries from newborn lambs (aged 3-5 d) and young, nonpregnant adult sheep (aged 18-24 mo) killed by pentobarbital overdose. Up to eight ring segments of each artery type were sampled from each animal. From 20 newborn lambs, we harvested 240 artery segments, and from 28 adult sheep, we harvested a total of 448. When a single protocol was repeated with multiple segments from the same animal, we averaged the results into a single value before statistical analysis. All reported values of n refer to the number of animals, not the number of segments.
The initial treatment of all arteries was identical and has been described in detail previously (1) . Briefly, we cleaned the arteries of adipose and connective tissue and cut them into ring segments 3 mm in length. All arteries were denuded of vascular endothelium by mild mechanical abrasion, after which we mounted each vascular ring on paired wires between a force transducer (BG-10, Kulite Semiconductors, Ridgefield, NJ) and a post attached to a micrometer used to vary resting tension. In a Krebsbicarbonate solution containing (in mM) 122 NaCI, 25.6 NaHCO,, 5.56 dextrose, 5.17 KCI, 2.49 MgSO,, 1.60 CaCI,, 0.114 ascorbic acid, and 0.027 disodium EDTA, continuously bubbled with 95% 0, and 5% CO, and maintained at 38S°C (normal ovine core temperature), we slowly and repeatedly stretched freshly mounted arteries until optimum baseline tensions of 1 g for the common carotid and 0.5 g for the basilar arteries (1) remained stable for at least 30 min. We then contracted the arteries with an isotonic potassium Krebs solution containing 122 mM K+ and 31 mM Na+. After peak tensions were reached, we washed the arteries with normal sodium Krebs and allowed them to reequilibrate at baseline tension for another 30 min. Endothelial denudation was then verified by the absence of a vasodilator response to the endothelium-dependent vasodilator A23187 (calcium ionophore, 1 pM) in precontracted arteries. Treatment of the artery segments thereafter varied with each protocol. During all experiments, we continuously digitized, normalized, and recorded contractile tensions using an on-line computer.
We conducted three experimental protocols. First, we determined the dose-response relations for the vasorelaxants SNAP and NG. Second, we determined the relaxation time courses for each agent at a dose of 10 pM. Finally, we determined the relations between the levels of the intracellular second messenger guanosine 3 ' 3 ' -cyclic monophosphate (cGMP) and the duration of exposure to SNAP and NG.
Dose-response experiments. Following the regimen described above, we induced a second contraction using a mixture of 20 pM histamine with 10 pM serotonin. Previous studies have shown this mixture to produce stable maximal contractions in ovine cerebral arteries (1). Once stable tone was established, we added cumulative doses of either SNAP or NG in aqueous solution to the tissue baths. Both agents were given in Yz-log increments to yield bath concentrations between lo-" and lop4 M. Because SNAP is somewhat unstable in solution, it was prepared immediately before use and held on ice. We calculated and expressed relaxant responses as the percentage of relaxation of the maximum initial tone attained in each vessel type. The maximum percentage of relaxation, pD, value (negative log of the ED,,,), and Hill coefficient (related to slope) for each dose-response relation were determined by fitting the normalized doseresponse relation with the logistic equation using computerized nonlinear regression.
Vasoreluxution experiments. The artery segments used in our second protocol were also contracted with high potassium Krebs, washed, rested, and contracted with the mixture of serotonin and histamine as described above. After the establishment of stable contractile tone, we added either 10 pM SNAP or 10 pM NG to the baths and recorded the resulting changes in tension as a function of time. All relaxations were normalized relative to maximum initial contractile tension. Rates of relaxation were determined by fitting the relaxation time courses to a monoexponential decay model with a non-zero asymptote (y = ~e -~' + B) using computerized nonlinear regression, as previously described (16) . In this model, y is the percent initial tone remaining at time t, A is the magnitude of maximum relaxation, B is the asymptotic value of tone remaining at infinite time, and k is the rate constant for relaxation.
Cyclic nucleotide responses. In arteries from a third group of animals, we determined the relations between cGMP and the duration of exposure to either 10 pM SNAP or 10 pM NG. We obtained a maximum of eight segments of each artery type from each animal, and all were studied simultaneously. We contracted the arteries with high potassium Krebs, washed them, and contracted them again with the mixture of serotonin and histamine as described above. After the establishment of stable tone, we froze one segment by rapid immersion in liquid nitrogen. This segment was used to determine the control levels of cGMP. We then added either 10 pM SNAP or 10 pM NG to the remaining segments, which were then flash frozen at 10-s intervals, up to a maximum of 100 s after relaxant addition. Thus, from each animal used in these experiments, we obtained a set of artery segments whose treatment varied only by the duration of exposure to the vasorelaxant used. To verify that the agents used produced no significant changes in CAMP, all samples were also routinely assayed for CAMP.
Cyclic nucleotide and protein detenninations. Artery segments designated for cyclic nucleotide analysis were stored at -80°C until assay, at which time they were individually homogenized in 1 mL of ice-cold 6% trichloroacetic acid using a motor-driven ground-glass pestle and mortar (Lurex, Vineland, NJ). After centrifuging the homogenates for 60 min at 3000 x g, we reserved the resultant pellet for protein determination and decanted the supernatants for subsequent cyclic nucleotide assay. For protein content determinations, we used an extraction (60 min in 1.0 M NaOH at 37OC) designed to exclude connective tissue and structural proteins, as previously described (1). We quantified protein using the Bradford Coomassie brilliant blue assay. As we have shown previously, this assay produces protein values that are both consistent and uniform in the vessel types studied (1).
For cyclic nucleotide determinations, we extracted the reserved supernatants with water-saturated diethyl ether, then lyophilized aliquots of the aqueous phase, reconstituted them in 50 mM acetate buffer, and assayed for cyclic nucleotides using standard RIA techniques. We determined both cGMP and cAMP content for each sample using commercially available kits (RPA 525 and RPA 509, Amersham Corp., Arlington Heights, IL). Both CAMP and cGMP values were normalized relative to vessel protein content and were expressed as pmol per mg of vessel protein.
Assay validation. Given our interest in the relative effects of SNAP and NG on the levels of cGMP and cAMP and the possibility of interactions between these cyclic nucleotides, we evaluated the sensitivity and specificity of the assays used. Prior experience with commercially prepared cyclic nucleotide RIA kits indicated an unacceptable level of cross-reactivity between the antibodies for cGMP and cAMP provided with some kits. We determined specificity by overloading the assays for cAMP and cGMP with known amounts of cGMP (7200 fmol) and cAMP (4800 fmol), respectively. In each case, under the conditions we used, the assays selected for this study failed to recognize ("undetectable") the added competing cyclic nucleotide. Standard curves for both assays covered the range of 1.5 to 96 fmol per 75-pL sample and thus encompassed the range of values of cGMP and cAMP seen in our samples. Therefore, the amounts of cGMP and cAMP added to test specificity represented considerable excesses over the levels normally seen.
Under our conditions, the assays we used consistently and reproducibly quantified low levels (1.5 fmol per 75-pL sample) of both cyclic nucleotides in our samples. Intraassay duplicate errors were 6% or less, and interassay errors averaged less than 8%. X 2 values for our standard curves were consistently close to 1.0. The protein assay against which the cyclic nucleotide values were normalized routinely gave duplicate errors of 4 % and standard curve r2 values of 0.995 or better. Thus, we believe that the values of cGMP and cAMP measured in this study were accurate and specific.
Statistics. All values were calculated as the mean 5 SEM. In all cases, n refers to the number of animals used in a given experimental group. For all data sets, we evaluated the homogeneity of variance assumption among subsets (homoscedasticity) using Bartlett's test. Where homoscedasticity was verified across groups under the same treatment (SNAP or NG), we used either one-way or two-way ANOVA with maturational age (newborn or adult) as one factor and artery type (common carotid or basilar) as the other. From each ANOVA, there were up to three statistical results: 1) age effect; 2) artery effect; and 3) interaction effect. For ANOVA with one or more statistically significant results, we calculated individual post-hoc differences between treatments of a given vessel type using Duncan's multiple range test. For data sets where homoscedasticity was not observed, we performed single one-time comparisons between corresponding newborn and adult arteries using a Behren's Fisher analysis with pooled weighted variance. Unless otherwise indicated, statistical significance implies p < 0.05.
RESULTS
We performed three basic analyses. First, we compared results between ages for each artery-treatment combination. Second, we compared treatments (SNAP versus NG) between each age-artery combination. Finally, we compared between artery types within each age-treatment combination.
Dose-response experiments. The cumulative doseresponse relations for both SNAP and NG are shown in Figure 1 , and the values of the coefficients obtained by fitting these data with the logistic equation are given in Figure 2 . As indicated in the upper panels of Figure 2 , maximum efficacy decreased significantly with age across all four artery-treatment groups. In the common carotid arteries, values of maximal relaxation averaged 95. Although pD, values (-log ED,,) tended to decrease with age in the common carotid and increase with age in the basilar arteries, pD2 changed significantly only for common carotid segments treated with NG (Fig. 2, mid- dle panels). In the common carotid arteries, pD2 values values were significantly greater for NG than for SNAP in both newborn and adult common carotid segments. Significant differences between common carotid and basilar pD, values occurred for SNAP in the adult and for NG in the newborn.
The slopes of the dose-response relations, as indicated by values of the Hill coefficient, increased significantly with age in arteries treated with NG (Fig. 2, lowerpan Vasorelawtion time course. Relaxations to a single dose of either SNAP or NG were generally complete within 120 s in all arteries (Figs. 3 and 4) . The rate coefficients for relaxation tended to decrease with age in the common carotid arteries and increase with age in the basilar arteries, but none of these differences were significant. Rate coefficients in the common carotid arteries averaged 1.06 were significantly greater for SNAP than for NG only in adult basilar segments. Corresponding rate values were generally greater in basilar than in common carotid segments, and these differences were significant in all but newborn arteries treated with NG.
Cyclic nucleotide responses. CAMP responses were not significant in any artery of either age group treated with either SNAP or NG (Table 1 ). In contrast, control cGMP levels (at time zero in Figs. 3 and 4) were significantly greater in newborn than in adult arteries and averaged 1.04 2 0.14 (newborn common carotid), 0.28 + 0.08 (adult common carotid), 3 (Fig. 5, upper panels) the common carotid than in the basilar arteries, in both newborns and adults.
In all arteries of both the newborn and the adult, administration of either SNAP or NG produced rapid increases in cGMP that peaked between 30 and 60 s and then returned toward baseline (Figs. 3 and 4) . In all cases, peak cGMP values were attained earlier in adult arteries (common carotid: 50 s; basilar: 30 s) than in corresponding newborn arteries (common carotid: 60-80 s; basilar: 40-60 s). In addition, in both artery types, newborn values were significantly higher than corresponding adult values at one or more points in time after adult peaks had been reached; the newborn time courses were shifted to the right relative to those of the adults.
Peak cGMP values tended to be greater in newborn than in adult arteries but varied significantly with age only in basilar segments treated with NG. In the common Corresponding basilar values were 6.31 + 0.46, 5.54 + w than corresponding basilar values, and these differences were significant in all but adult arteries treated with NG.
DISCUSSION
The main finding of the present study is that maximum efficacy decreased with maturation for both SNAP-and NG-induced relaxation in common carotid and basilar arteries ( Figs. 1 and 2 ). This result is consistent with previous suggestions that the mechanisms necessary for cGMP-dependent relaxation are fully functional in newborn arteries of the cerebral (14, 15) and pulmonary (17, 18) circulations. It also suggests that the maturational improvements in endothelium-dependent vasodilation reported in these vascular beds (13, 14, 17) are more likely caused by functional changes in the endothelium than in the vascular smooth muscle of these arteries. From a clinical perspective, our results support the hypothesis that newborn cerebral arteries have a greater propensity to relax than corresponding adult arteries, at least in response to vasodilator stimuli dependent on guanylate cyclase activation. In turn, the greater tendency of newborn cerebral arteries to relax could contribute, at least theoretically, to the greater incidence of intracranial artery rupture observed in neonates relative to adults. (2, 3)-From a mechanistic perspective, the present results suggest that the capacity of the cGMP pathway to produce relaxation is attenuated by maturation. This attenuation does not seem to involve changes in the sensitivity to nitric oxide, because the ED,, concentrations for SNAP did not change with age (Fig. 2) . Although the ED,, concentration for NG did increase slightly with age in the common carotid, this difference is probably secondary to maturational increases in wall thickness and thus diffusion distance, which are well documented in this artery (1) . Whereas SNAP releases nitric oxide spontaneously upon hydration, NG must diffuse into the smooth muscle cells where it can be biotransformed to release nitric oxide (19, 20) . Thus, the absence of an age-related change in sensitivity to SNAP in the common carotid artery may be attributed to the greater diffusabil- ity of nitric oxide released into solution by SNAP relative to the diffusability of the much larger NG molecule. This interpretation would also explain why age-related differences in sensitivity were not observed for either SNAP or NG in the relatively thin-walled basilar artery.
Another difference between responses to SNAP and NG was indicated by the Hill coefficient results. As calculated in the present study, the Hill coefficients quantify the slope of the relation between input (drug concentration) and output (relaxation response) and may be taken as a simple index of dose-response "gain." As such, the Hill coefficient results suggest that doseresponse gain increases with age for NG but not for SNAP. Because the mechanisms mediating relaxation subsequent to nitric oxide release are the same for SNAP and NG, the main difference between responses to these agents is that NG requires biotransformation and SNAP does not. Thus, we attribute the finding that the Hill coefficients increased significantly with age in both artery types for NG but not for SNAP to a maturational improvement in the capacity for the biotransformation of NG, as previously suggested (14).
The present results further suggest that the age-related decrease in the efficacy of SNAP and NG cannot be explained by a decrease in the peak amount of cGMP synthesized in response to a given concentration of nitric oxide. Peak cGMP levels produced by 10 p,M SNAP or NG were, in general, not significantly affected by maturation (Figs. 3 and 4) . The time courses of the cGMP responses, however, were right-shifted in the newborn arteries, suggesting that the turnover of cGMP varied with age. Consistent with this interpretation, baseline cGMP levels were significantly higher in newborn than in adult arteries. These differences suggest that, relative to the rate for cGMP synthesis, the rate for cGMP breakdown may be higher in adult than in newborn arteries. Although intracellular cGMP concentration might also be reduced by extrusion from the cell, studies in adult rat aorta (21) suggest that the rate of cGMP extrusion is far slower than the rate of cGMP degradation by phosphodiesterase (22) . Thus, age-related differences in cGMP turnover probably arise from differences in the relative rates of cGMP synthesis by guanylate cyclase or cGMP hydrolysis by phosphodiesterase. An important effect of -.. t In three cases, cAMP tended to decrease in response to either NG or SNAP, in which case the minimum values attained are shown.
such differences in cGMP turnover would be that the area beneath the cGMP-time curve would be greater for newborn than for adult arteries, as was observed. By virtue of their effect on the area beneath the cGMPtime curve, maturational changes in cGMP turnover may at least partially explain the age-related decrease in maximum efficacy for SNAP and NG observed in the present experiments. Greater area beneath the cGMP-time curve should yield a greater total activation of G-kinase and greater phosphorylation of the proteins activated by G-kinase. This effect, in turn, could contribute to the greater relaxation observed in the newborn arteries. However, changes in the relation between cGMP concentration and relaxation may also be involved. The fact that relaxation persists long after cGMP has returned to baseline indicates that the duration of relaxation is determined by some process downstream from cGMP, possibly by smooth muscle phosphatase activity, which ultimately reverses the effect of G-kinase (23) . Smooth muscle phosphatase activity could vary with age, although this possibility remains unexplored at present. Alternatively, the abundance or biochemical characteristics of the proteins phosphorylated by G-kinase might vary with age, which could potentially alter the relation between cGMP and relaxation as well as the maximum efficacy of nitric oxide. Given this range of possibilities, the present data can be taken to indicate only that a change in cGMP turnover probably plays some part in the maturational decease in the maximum efficacy for SNAP and NG.
One hint that maturation may change the relation between cGMP and relaxation is provided by the dynamic aspects of the present data. To examine these dynamics, we calculated the amount of relaxation attained when peak cGMP concentration was reached (Fig. 5, toppanels) . In all cases, relaxation was more complete in newborn than in adult arteries at peak cGMP. Rates of relaxation, however, did not vary significantly with age (Fig.  5, bottom panels) . These findings demonstrate that the dynamic relation between vascular cGMP and relaxation was different in newborn and adult arteries; although cGMP rose more slowly and was more sustained in the newborn arteries, their rate of relaxation was similar to that observed in the adult arteries. It remains possible, however, that the rate-limiting determinant of relaxation was similar in newborn and adult arteries. For example, if the initial rates of change in cGMP in these experiments were fast compared with the velocity of phosphorylation by G-kinase (24) or the physiologic effect of this phosphorylation (25, 26) , these later steps may have governed relaxation rate (8) . Similarly, if the cGMP changes in these experiments were supramaximal for activation of G-kinase, the cGMP time course need not bear any dynamic relation to relaxation rate. Clearly, many additional experiments will be required to determine why the cGMP time course changed with age but the rate of relaxation did not.
One final feature of the present results worthy of note concerns the modest differences observed between comCommon Carotid Basilar Artery I I I
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mon carotid and basilar artery responses. Basilar arteries relaxed significantly faster than common carotid arteries in both newborns and adults, a finding probably related to differences in wall thickness and diffusional path length, as mentioned above. In association with these differences in relaxation rate, basilar arteries exhibited greater relaxation at peak cGMP than did corresponding common carotid arteries. Basilar arteries also had significantly greater basal levels of cGMP, suggesting that the balance between cGMP synthesis and degradation is tipped toward greater synthesis in the basilar arteries. Despite these and other minor differences, no significant differences in maximum efficacy or the effects of maturation thereupon were observed between basilar and common carotid arteries. This latter observation suggests that the influences governing changes in maximum efficacy are a generalized feature of maturation and are not specific for either intracranial or extracranial arteries. What these influences are and how they are coordinated with the myriad other changes accompanying maturation remain almost completely unexplored and thus constitute a promising and important topic for future investigations. between groups are as indicated in the legend for Figure 2 .
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